RxSight, Inc. (RXST) Tops Q1 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
RxSight Inc. (RXST) PT Raised to $75 at Stifel
May 7, 2024 6:04 AM EDTStifel analyst Tom Stephan raised the price target on RxSight Inc. (NASDAQ: RXST) to $75.00 (from $68.00) while maintaining a Buy rating.
The analyst comments "RXSTs 1Q24 results confirmed (and then some) why it has been viewed as one of the best 2024 momentum stories... More
RxSight Inc. (RXST) PT Raised to $68 at Wells Fargo
May 7, 2024 5:53 AM EDTWells Fargo analyst Lawrence Biegelsen raised the price target on RxSight Inc. (NASDAQ: RXST) to $68.00 (from $61.00) while maintaining a Overweight rating.
The analyst comments "We raise our 2024 EPS estimate from -$1.02 to -$0.86. Our price target increases to $68 (from $61) based on 13x (from 11x... More
RxSight Inc. (RXST) PT Raised to $72 at BTIG
May 7, 2024 5:19 AM EDTBTIG analyst Ryan Zimmerman raised the price target on RxSight Inc. (NASDAQ: RXST) to $72.00 (from $61.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy and raise our PT to $72 PT (from $61) following 1Q24 results. RXST delivered a strong start to FY24 with 1Q24 revenue of $29.5M (69% Y/Y) and adj. LPS of $(0.25)... More

